Mr. Speaker, our hearts go out to patients who have had adverse drug reactions. Our government has taken a leadership role in working with the provinces and territories to develop ways that we can work with them to address this issue. We do see it as a very significant part of the Canadian health care system.
In the House of Commons on November 1st, 2012. See this statement in context.